What are the causes of eosinopenia (low eosinophil count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Low Eosinophils (Eosinopenia): Causes and Clinical Significance

Eosinopenia (eosinophil count ≤30-50/µL or <0.05 × 10⁹/L) most commonly results from acute bacterial infections, severe systemic inflammation, or corticosteroid administration, and serves as a marker of disease severity and poor prognosis in critically ill patients.

Primary Causes of Eosinopenia

Acute Infections and Inflammation

The most frequent cause of low eosinophils is acute bacterial infection or severe systemic inflammation 1. During acute inflammatory processes, eosinophils rapidly:

  • Accumulate at inflammatory sites (peripheral sequestration)
  • Experience inhibited egress from bone marrow
  • Undergo suppressed eosinopoiesis with prolonged inflammation

This response occurs regardless of pathogen type—bacterial (pneumococcal, E. coli), viral (Coxsackie), or sterile inflammation (turpentine-induced) 1.

Severe Community-Acquired Pneumonia

Eosinopenia ≤30/µL predicts respiratory failure and mortality in hospitalized pneumonia patients 2, 3:

  • Mechanical ventilation rates: 15.5% vs 7.3% in non-eosinopenic patients (RR 2.12)
  • ICU admission rates: 23.1% vs 10.9% (RR 2.11)
  • 30-day mortality independently increased (HR 1.95)
  • Longer hospital stays among survivors

This threshold remains predictive regardless of corticosteroid treatment 2.

Sepsis and Critical Illness

Persistently low eosinophil counts associate with adverse outcomes in sepsis, though the mechanistic contribution remains incompletely understood 4. Eosinopenia reflects the severity of systemic inflammatory response.

Secondary Causes

Corticosteroid Administration

Glucocorticoids cause rapid eosinopenia through:

  • Redistribution from circulation to tissues
  • Suppression of eosinophil production
  • Enhanced apoptosis

This is one of the most common iatrogenic causes in clinical practice.

HIV Infection

HIV can present with eosinophilia or eosinopenia 5, 6. When evaluating travelers or migrants with abnormal eosinophil counts, HIV testing is recommended as part of the differential workup 5.

Autoimmune Conditions

In chronic spontaneous urticaria, eosinopenia (present in 10% of patients) associates with 7:

  • Type IIb autoimmunity (positive autologous serum skin test)
  • High disease activity
  • Poor response to antihistamines (OR 4.8) and omalizumab
  • Low total IgE and elevated C-reactive protein
  • When combined with basopenia: OR 9.5 for treatment nonresponse

Clinical Approach to Eosinopenia

Immediate Assessment

  1. Medication review: Check for recent corticosteroid use (systemic or high-dose inhaled)
  2. Infection screening: Look for signs of acute bacterial infection, pneumonia, or sepsis
  3. Severity markers: Assess for systemic inflammatory response (fever, tachycardia, hypotension, elevated CRP)

Risk Stratification

In hospitalized patients with pneumonia or sepsis, eosinophil count ≤30/µL mandates:

  • Closer monitoring for respiratory deterioration
  • Lower threshold for ICU-level care
  • Anticipation of longer hospital course
  • Recognition as independent mortality predictor

Differential Considerations

Eosinopenia is not typically caused by:

  • Helminth infections (these cause eosinophilia) 5, 6
  • Allergic conditions (these cause eosinophilia)
  • Eosinophilic esophagitis (requires ≥15 eosinophils/hpf for diagnosis) 8, 9

Key Clinical Pitfalls

Do not dismiss eosinopenia as clinically insignificant—it is a simple, inexpensive biomarker that:

  • Predicts clinical deterioration in acute infections
  • Identifies high-risk patients requiring escalation of care
  • Reflects severity of systemic inflammation
  • May indicate treatment-resistant autoimmune disease

Avoid attributing eosinopenia solely to corticosteroids without excluding acute infection, as both may coexist and the prognostic value persists independent of steroid use 2.

The combination of eosinopenia with basopenia creates an even stronger predictor of poor outcomes in inflammatory conditions 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.